Background
==========

Ovarian cancer has a high mortality rate, which ranks first among gynecologic malignant tumors. Most deaths (70%) of patients presented with advanced-staged, high-grade serous ovarian cancer (HGSOC) due to the lack of specific symptoms at the early stage \[[@b1-medscimonit-26-e922107]\]. Therefore, it is of great significance to study the potential prognostic biomarkers related to the development of HGSOC.

In recent years, bioinformatics-assisted analyses of expression profile have been widely used to detect the biomarkers of human diseases \[[@b2-medscimonit-26-e922107]\]. Weighted gene co-expression network analysis (WGCNA) is a biological approach to determine highly synergistic gene sets and to identify the association between gene modules and phenotype of samples \[[@b3-medscimonit-26-e922107]\]. WGCNA has been comprehensively utilized in multiple cancer-associated studies to determine hub genes that could be associated with respective traits, such as pancreatic carcinoma \[[@b4-medscimonit-26-e922107]\], colon cancer \[[@b5-medscimonit-26-e922107]\], and ovarian cancer \[[@b6-medscimonit-26-e922107]--[@b10-medscimonit-26-e922107]\]. However, few previous studies have focused on HGSOC.

To identify potential biomarkers for specific diagnosis and therapy targets in HGSOC, WGCNA was performed to discover the hub genes that play an essential role in the development of HGSOC.

Material and Methods
====================

Data collection
---------------

Five gene expression profiles were downloaded from the Gene Expression Omnibus (GEO) (*<http://www.ncbi.nlm.nih.gov/geo/>*). Datasets GSE18520 \[[@b11-medscimonit-26-e922107]\], GSE27651 \[[@b12-medscimonit-26-e922107]\], GSE54388 \[[@b13-medscimonit-26-e922107]\], GSE10971 \[[@b14-medscimonit-26-e922107]\] and GSE14001 \[[@b15-medscimonit-26-e922107]\] are listed in [Supplementary Table 1](#s1-medscimonit-26-e922107){ref-type="supplementary-material"}, with a sample size of 114 for HGSOC and 49 normal tissue samples. All samples were processed using the Affymetrix human genome U133 plus 2.0 array. Genomic and clinical data were obtained from The Cancer Genome Atlas (TCGA) (*<https://cancergenome.nih.gov/>*) and GTEx (*<https://gtexportal.org/home/>*) \[[@b16-medscimonit-26-e922107]\] using the TCGAbiolinks package (Version 2.14.0; *<https://github.com/BioinformaticsFMRP/TCGAbiolinks>*) \[[@b17-medscimonit-26-e922107]\]. The RNA expression profiles were sampled from 363 high-grade serous ovarian cancer and 108 normal tissues.

Research design and data preprocessing
--------------------------------------

The research design is shown in a flowchart ([Figure 1](#f1-medscimonit-26-e922107){ref-type="fig"}). The raw data from 5 datasets were chosen for integrated analysis using the affy package (Version 3.8; *<http://bioconductor.org/packages/release/bioc/html/affy.html>*) \[[@b18-medscimonit-26-e922107]\]. The batch effect of datasets was removed using the SVA package (Version 3.8; *<http://bioconductor.org/packages/release/bioc/html/sva.html>*) with its combat function ([Supplementary Figure 1](#s2-medscimonit-26-e922107){ref-type="supplementary-material"}) \[[@b19-medscimonit-26-e922107]\].

Differential gene expression analysis
-------------------------------------

We detected the DEGs between HGSOC and normal ovarian tissue samples using the limma package (Version 3.30.0; *<http://www.bioconductor.org/packages/release/bioc/html/limma.html>*) \[[@b20-medscimonit-26-e922107]\]. A false discovery rate (FDR) \<0.05 and \|log~2~FC\|\>1 were set as the criteria value. The expression intensity and direction of DEGs were represented using the pheatmap package (Version 1.0.12, *<https://cran.r-project.org/web/packages/pheatmap>*).

Function enrichment analyses
----------------------------

Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analyses of DEGs were conducted using the clusterProfiler package (Version 6.8; *<http://www.bioconductor.org/packages/release/bioc/html/clusterProfiler.html>*) \[[@b21-medscimonit-26-e922107]\] to predict their underlying molecular functions. A p value of \<0.05 was considered statistically significant.

Weighted gene co-expression network analysis (WGCNA)
----------------------------------------------------

We utilized the WGCNA package (Version 1.67; *<https://cran.r-project.org/web/packages/WGCNA/index.html>*) to construct a co-expression network for DEGs. To identify key modules, soft-thresholding power was set as β=9 (scale-free R^2^=0.84), and cut height was set as 0.25 ([Supplementary Figure 2](#s3-medscimonit-26-e922107){ref-type="supplementary-material"}). We then explored the biological function of the modules that had the highest correlation with traits through GO and KEGG pathway analyses, and hub genes in a module were selected with \|MM\|\>0.85 and \|GS\|\>0.3.

Survival analysis and expression validation of hub genes
--------------------------------------------------------

Survival analysis was performed for hub genes using the survival package (Version 2.43.3; *<https://cran.r-project.org/package=survival>*) and survminer package (Version 0.4.3; *<https://cran.r-project.org/package=survminer>*). The Kaplan-Meier curves were plotted by the expression profiles from TCGA, which were divided into 2 groups based on a certain gene's cutoff value as determined by survminer. The hub gene expression levels between HGSOC and normal tissue samples were also validated.

Gene set enrichment analysis (GSEA)
-----------------------------------

GSEA analysis of each hub gene with the TCGA-OV dataset was performed. The HGSOC samples (n=363) were divided into 2 groups according to the median expression value of each hub gene (high *vs.* low). A p value of \<0.05 was considered as statistically significant. The "h.all.v6.2.entrez.gmt" were selected as reference gene sets, which were downloaded from the Molecular Signature Database (MSigDB, *<http://software.broadinstitute.org/gsea/msigdb>*).

Results
=======

Differential expression analysis
--------------------------------

We screened 1874 DEGs, including 919 downregulated and 956 upregulated genes, between HGSOC samples and normal tissue samples. The expression changes of DEGs were represented by a heatmap ([Supplementary Figure 3](#s4-medscimonit-26-e922107){ref-type="supplementary-material"}), which showed that the samples were divided into 2 clusters.

Function enrichment for DEGs
----------------------------

The potential biological functions of the upregulated and downregulated differentially-expressed genes were annotated by clusterProfiler R package. The KEGG pathway analysis revealed that the upregulated genes were mainly involved in regulation of cell cycle, DNA replication, and biosynthesis of amino acids, while the downregulated genes were mainly linked to the Ras signaling pathway, complement and coagulation cascades, and the MAPK and JAK-STAT signaling pathways ([Figure 2](#f2-medscimonit-26-e922107){ref-type="fig"} and [Supplementary Table 2](#s5-medscimonit-26-e922107){ref-type="supplementary-material"}). Furthermore, we performed GO enrichment analysis, the biological progress of which was in line with the KEGG enrichment results. Chromosome segregation and mitotic nuclear division were indicated for the upregulated genes, while morphogenesis of an epithelium and collagen-containing extracellular matrix were indicated for the downregulated genes ([Figure 3](#f3-medscimonit-26-e922107){ref-type="fig"} and [Supplementary Table 3](#s6-medscimonit-26-e922107){ref-type="supplementary-material"}).

Co-expression modules construction
----------------------------------

To construct co-expression modules and find the key modules related to HGSOC, the expression profiles of 1874 DEGs were assessed with the WGCNA package. Hierarchical clustering analysis is presented in [Figure 4A](#f4-medscimonit-26-e922107){ref-type="fig"}. Then, the highly related genes were put into modules. The MED threshold was set as 0.25, and 6 modules were excavated ([Figure 4B](#f4-medscimonit-26-e922107){ref-type="fig"}). The genes that did not belong to any module were collected in the gray module, and were not used in any subsequent analysis. The other 5 modules are shown in blue, turquoise, yellow, brown, and green, respectively ([Figure 4C](#f4-medscimonit-26-e922107){ref-type="fig"}). Among the 5 modules, the turquoise and blue modules had remarkable relevance for tumor progression ([Figure 4C, 4D](#f4-medscimonit-26-e922107){ref-type="fig"}).

Moreover, intramodular analysis for GS and MM resulted in the identification of genes in the turquoise module, which were negatively correlated with HGSOC (correlation=0.75 and p\<9.5e--155) and genes in the blue module revealed a highly positive correlation with HGSOC (correlation=0.7 and p\<3.2e--118), as shown in [Figure 5A](#f5-medscimonit-26-e922107){ref-type="fig"}.

The heatmap was plotted to show all genes ([Figure 5B](#f5-medscimonit-26-e922107){ref-type="fig"}). To quantify co-expression similarity of the 5 modules, we calculated the connectivity of eigengenes. Positively correlated eigengenes were grouped together, with 2 of 5 modules were classified into one cluster and 3 into another. The heatmap of the adjacencies is also presented ([Figure 5C](#f5-medscimonit-26-e922107){ref-type="fig"}).

There were 76 hub genes from the turquoise module and 76 hub genes from the blue module selected, with a threshold module membership (MM) \>0.85 and gene significance (GS) \>0.3 ([Supplementary Table 4](#s7-medscimonit-26-e922107){ref-type="supplementary-material"}).

The turquoise and blue modules were analyzed by STRING database, with a combined score \>0.7 and were visualized by Cytoscape software ([Figure 6](#f6-medscimonit-26-e922107){ref-type="fig"}).

To investigate the potential functions of the genes within the 2 modules (turquoise and blue), we performed GO and KEGG pathway analyses, and showed the most significant GO terms and KEGG pathways in [Figure 7](#f7-medscimonit-26-e922107){ref-type="fig"}. This analysis revealed that genes in the blue module were mainly enriched in cell cycle and DNA replication, while genes in the turquoise module played their roles in different signal pathways.

Validation of hub genes
-----------------------

Analyzing the results of WGCNA, we found that the turquoise and blue modules had the highest association with HGSOC. Accordingly, we hypothesized that the genes in the turquoise module might act as tumor suppressors and genes in the blue module might act as tumor promoters. Survival analyses were performed among the 152 hub genes selected from the 2 modules. We found that *MAD2L1* and *FANCD2* in the blue module and *PKD2*, *TBRG1*, and *DOCK5* in the turquoise module were consistent with our speculation. Survival curves showed that higher expression of *MAD2L1* and *FANCD2* was significantly associated with poor prognosis of patients, as was the lower expression of *PKD2*, *TBRG1*, and *DOCK5* ([Figure 8](#f8-medscimonit-26-e922107){ref-type="fig"}). Finally, we used gene profiles downloaded from TCGA and GTEx to validate the expression of these genes, and the results were similar to the expression exhibited by GEO ([Figure 9](#f9-medscimonit-26-e922107){ref-type="fig"}).

Potential function of hub genes through GSEA
--------------------------------------------

To better understand the potential biological functions of *MAD2L1*, *FANCD2*, *PKD2*, *TBRG1*, and *DOCK5* in HGSOC, we performed GSEA based on the TCGA-OV dataset. As shown in [Figure 10](#f10-medscimonit-26-e922107){ref-type="fig"}, genes in higher-expression groups of *MAD2L1* and *FANCD2* were all involved in "E2F TARGETS" and "G2M CHECKPOINT" of the cell cycle, which indicated that these 2 upregulated genes are closely associated with tumor proliferation, whereas "TNFA SIGNALING VIA NFKB", "interferon gamma RESPONSE" and "inflammatory response" were enriched in the *PKD2*, *TBRG1*, and *DOCK5* high-expression groups, which indicated these downregulated genes are involved in immune response ([Supplementary Table 5](#s8-medscimonit-26-e922107){ref-type="supplementary-material"}).

Discussion
==========

With the purpose of identifying the molecular mechanism of HGSOC and to investigate potential biomarkers for better detection and therapy, we integrated the gene expression profiles of GSE54388, GSE27651, GSE10971, GSE18520, and GSE14001, which contained 114 samples of HGSOC tissue and 49 samples of normal tissue.

We identified 1874 DEGs that were correlated with HGSOC, and the cutoff criteria were p\<0.05 and \|logFC\|≥1. In KEGG analysis, the upregulated genes were predominantly involved in cell cycle and DNA replication, while the downregulated genes were highly involved in Ras signaling, complement and coagulation cascades, and MAPK signaling pathways. The GO analysis supported the previous enrichment analysis, which both help to understand the role of DEGs in HGSOC.

WGCNA analysis was used to select co-expression modules related to the development of HGSOC, and 2 modules (blue and turquoise) were found to have the highest correlation with HGSOC. We showed the Protein--Protein Interactions (PPI) network and also performed GO and KEGG analyses for genes in the 2 modules. The results indicated that genes in the blue module were enriched in cell cycle and DNA replication, while genes in the turquoise module were involved in different signaling pathways. After filtering with MM and GS value, we detected 152 hub genes from the 2 modules. Five genes -- *MAD2L1* and *FANCD2* in the blue module and *PKD2*, *TBRG1*, and *DOCK5* in the turquoise module -- were excavated after survival analysis and expression validation with datasets downloaded from TCGA, and were found to have prognostic value for HGSOC. Among these 5 hub genes, *MAD2L1* and *FANCD2* are associated with ovarian cancer.

As a component of the mitotic checkpoint, high levels of *MAD2L1* are related to increased cellular proliferation, migration, and metastasis, which can lead to shorter survival in various cancers \[[@b22-medscimonit-26-e922107]--[@b26-medscimonit-26-e922107]\]. However, in ovarian cancer, the role of *MAD2L1* did not agree with previous findings that patients with lower *MAD2L1* levels were less sensitive to paclitaxel and had shorter progression-free survival (PFS) and overall survival (OS) \[[@b27-medscimonit-26-e922107],[@b28-medscimonit-26-e922107]\]. This discrepancy might have been caused by our analysis, ignoring the mutations of *p53* and *BRCA1*, which are known regulators of *MAD2L1* and are commonly mutated in HGSOC \[[@b29-medscimonit-26-e922107],[@b30-medscimonit-26-e922107]\].

High *FANCD2* levels have been shown to be associated with poor prognosis in many types of cancer \[[@b31-medscimonit-26-e922107]--[@b35-medscimonit-26-e922107]\], as well as in ovarian cancer \[[@b36-medscimonit-26-e922107]\]. *FANCD2* overexpression can stabilize the replication fork, and create *BRCA1/2* mutant tumor resistance towards PARP1/2 inhibitor treatments \[[@b37-medscimonit-26-e922107]\]. The results indicated that *FANCD2* expression can influence cancer sensitivity to *PARP1/2* inhibitors and thus could be used as a potential target of therapy.

To further explore the biological functions of the 5 selected hub genes, we conducted single-gene GSEA. "E2F TARGETS" and "G2M CHECKPOINT" were enriched in the high-expression groups of *MAD2L1* and *FANCD2*, indicating their contribution to HGSOC proliferation. In the high-expression groups of *PKD2*, *TBRG1*, and *DOCK5*, immune-related signals, such as "TNFA SIGNALING VIA NFKB", "INTERFERON GAMMA RESPONSE" and "INFLAMMATORY RESPONSE" were enriched, indicating the activity of immune response.

Conclusions
===========

We identified several DEGs and meaningful gene modules in HGSOC. Four valuable hub genes (*FANCD2*, *PKD2*, *TBRG1*, and *DOCK5*) were strongly dysregulated in HGSOC tissues. GSEA further suggested that *FANCD2* is associated with tumor proliferation, while *PKD2*, *TBRG1*, and *DOCK5* influence immune response. More work is needed to fully reveal their individual contributions towards the pathogenesis of HGSOC and to validate their value as prognostic biomarkers.

Limitations of this study include the lack of analysis for detailed clinical classification of HGSOC, such as grade, stage, lymph node metastasis, and prognosis. In future research, we will explore hub genes and their potential function based on this clinical information in detail.

Supplementary Data
==================

###### 

Characteristics of the included datasets.

  Dataset ID   GPL ID   High-grade serous ovarian carcinoma   Normal ovarian surface epithelium
  ------------ -------- ------------------------------------- -----------------------------------
  GSE18520     GPL570   53                                    10
  GSE27651     GPL570   22                                    6
  GSE54388     GPL570   16                                    6
  GSE10971     GPL570   13                                    24
  GSE14001     GPL570   10                                    3

###### 

Samples clustering of 5 datasets after removing the batch effects.

###### 

Soft-thresholding power determination in WGCNA. (**A**) Analysis of the scale-free fit index for different soft-thresholding powers. (**B**) Mean connectivity for various soft-thresholding powers. (**C**) Histogram of connectivity distribution when β=9. (**D**) Check scale-free topology when β=9.

###### 

Heatmap of the top 200 DEGs based on the value of \|logFC\|. High or low expression is shown as a red or blue strip, respectively. The experimental group was labelled HGSOC, while the control group was named Nor.

###### 

The KEGG enrichment analysis of genes.

  ID         Description                              p\. adjust   Count   Regulation
  ---------- ---------------------------------------- ------------ ------- ------------
  hsa04110   Cell cycle                               0.000633     35      up
  hsa03030   DNA replication                          0.012093     14      up
  hsa01230   Biosynthesis of amino acids              0.028478     12      up
  hsa04014   Ras signaling pathway                    0.007503     25      down
  hsa04610   Complement and coagulation cascades      0.007503     14      down
  hsa04010   MAPK signaling pathway                   0.007503     29      down
  hsa04630   JAK-STAT signaling pathway               0.007503     13      down
  hsa04728   Dopaminergic synapse                     0.007503     13      down
  hsa05032   Morphine addiction                       0.007503     13      down
  hsa04261   Adrenergic signaling in cardiomyocytes   0.013251     12      down
  hsa05146   Amoebiasis                               0.03213      14      down

###### 

The GO enrichment analysis of genes.

  Ontology   ID            Description                                                                                  p\. adjust   Count   Regulation
  ---------- ------------- -------------------------------------------------------------------------------------------- ------------ ------- ------------
  BP         GO: 0007059   Chromosome segregation                                                                       7.51E-30     76      up
  BP         GO: 0140014   Mitotic nuclear division                                                                     8.88E-28     69      up
  BP         GO: 0000280   Nuclear division                                                                             1.11E-26     83      up
  BP         GO: 0048285   Organelle fission                                                                            3.71E-25     85      up
  BP         GO: 0098813   Nuclear chromosome segregation                                                               5.13E-25     63      up
  CC         GO: 0098687   Chromosomal region                                                                           1.26E-26     74      up
  CC         GO: 0000775   Chromosome, centromeric region                                                               2.73E-24     53      up
  CC         GO: 0000793   Condensed chromosome                                                                         1.10E-20     52      up
  CC         GO: 0000779   Condensed chromosome, centromeric region                                                     2.30E-19     37      up
  CC         GO: 0005819   Spindle                                                                                      2.30E-19     62      up
  MF         GO: 0140097   Catalytic activity, acting on DNA                                                            2.32E-08     34      up
  MF         GO: 0008094   DNA-dependent ATPase activity                                                                1.57E-05     19      up
  MF         GO: 0016887   ATPase activity                                                                              0.000226     47      up
  MF         GO: 0043142   Single-stranded DNA-dependent ATPase activity                                                0.000325     7       up
  MF         GO: 0001077   Proximal promoter DNA-binding transcription activator activity, RNA polymerase II-specific   0.000325     35      up
  BP         GO: 0002009   Morphogenesis of an epithelium                                                               9.98E-07     53      down
  BP         GO: 0016049   Cell growth                                                                                  2.29E-06     52      down
  BP         GO: 0001822   Kidney development                                                                           6.68E-06     35      down
  BP         GO: 0072001   Renal system development                                                                     6.68E-06     36      down
  BP         GO: 0003002   Regionalization                                                                              6.68E-06     40      down
  CC         GO: 0062023   Collagen-containing extracellular matrix                                                     1.22E-11     49      down
  CC         GO: 0031012   Extracellular matrix                                                                         1.29E-10     59      down
  CC         GO: 0042383   Sarcolemma                                                                                   3.36E-05     21      down
  CC         GO: 0005604   Basement membrane                                                                            3.64E-05     17      down
  CC         GO: 0031252   Cell leading edge                                                                            0.006422     34      down
  MF         GO: 0005201   Extracellular matrix structural constituent                                                  4.99E-05     24      down
  MF         GO: 0005539   Glycosaminoglycan binding                                                                    5.13E-05     29      down
  MF         GO: 1901681   Sulfur compound binding                                                                      6.67E-05     30      down
  MF         GO: 0008201   Heparin binding                                                                              0.000129     23      down
  MF         GO: 0005518   Collagen binding                                                                             0.000836     13      down

###### 

Hub genes in blue and turquoise module (\|MM\|\>0.85 and \|GS\|\>0.3).

  Blue module   Turquoise module                                      
  ------------- ------------------ ---------- ------------ ---------- ----------
  CSE1L         0.885182           0.654936   LRRN4        0.863969   −0.76695
  PCNA          0.853268           0.634531   LINC01105    0.85413    −0.83749
  HNRNPAB       0.859002           0.665006   DAB2         0.928442   −0.84279
  TOP2A         0.891679           0.822887   CELF2        0.888927   −0.77641
  SMC4          0.917093           0.806692   LAMA4        0.850672   −0.68463
  MTHFD2        0.877458           0.806098   SPOCK1       0.867854   −0.80181
  PSRC1         0.871528           0.788497   PAPSS2       0.879786   −0.72486
  CKS1B         0.934063           0.787083   DAPK1        0.899065   −0.7982
  MCM2          0.922548           0.841694   PROCR        0.898493   −0.7677
  PCLAF         0.899258           0.817579   PKD2         0.929768   −0.75857
  CRABP2        0.87272            0.877783   GSDME        0.91672    −0.80166
  CCNB2         0.897672           0.848503   IGFBP6       0.892364   −0.79082
  LSM4          0.871655           0.664114   THBD         0.869457   −0.80323
  CDC20         0.893728           0.758763   KDR          0.884189   −0.74272
  UBE2C         0.876499           0.834623   FRY          0.899738   −0.80017
  CDK1          0.876549           0.8119     GNG11        0.930805   −0.75466
  EZH2          0.862178           0.795034   ABCA8        0.944703   −0.89654
  MAD2L1        0.889283           0.76929    GPRASP1      0.899009   −0.87775
  PTTG1         0.870574           0.824798   GFPT2        0.866683   −0.7817
  BUB1B         0.892962           0.819369   RNASE4       0.903103   −0.80729
  DLGAP5        0.877017           0.82571    CALB2        0.897513   −0.85688
  ZWINT         0.922712           0.79987    BCHE         0.922752   −0.81917
  TRIP13        0.884367           0.77344    NPY1R        0.882911   −0.85536
  RAD51AP1      0.858395           0.802612   GHR          0.888245   −0.71151
  NDC80         0.86773            0.721595   ECM2         0.850415   −0.66158
  CKS2          0.94052            0.829763   ARHGAP6      0.869659   −0.73929
  KIF11         0.885283           0.822206   WNT2B        0.877108   −0.80996
  NEK2          0.89035            0.839637   PTGIS        0.883089   −0.79366
  KIF23         0.853223           0.7629     LGALS2       0.85777    −0.75854
  FEN1          0.909533           0.760884   MAF          0.898868   −0.73781
  TTK           0.894859           0.855031   SYNE1        0.854181   −0.8207
  MELK          0.900554           0.813158   PLPP1        0.920489   −0.7545
  STIL          0.867957           0.835405   TCEAL2       0.877183   −0.81491
  SAC3D1        0.874805           0.712282   TBC1D2B      0.862424   −0.70643
  HMGA1         0.869641           0.806441   PDE8B        0.878248   −0.91687
  GINS1         0.893705           0.7861     ATP10D       0.88824    −0.74775
  CENPF         0.880011           0.84842    TFPI         0.86169    −0.75802
  AURKA         0.914224           0.801243   CHN2         0.855714   −0.81706
  EIF4G1        0.869979           0.737708   BICC1        0.864204   −0.82881
  NR2F6         0.887103           0.752212   DIXDC1       0.858203   −0.8161
  BUB1          0.913764           0.809106   DIRAS3       0.875531   −0.8524
  PUF60         0.866461           0.739985   OLFML1       0.886786   −0.70603
  TPX2          0.862716           0.819783   CSGALNACT1   0.90082    −0.83324
  RPL39L        0.857416           0.742065   PDGFD        0.866505   −0.68393
  EIF6          0.86057            0.671087   RADX         0.868631   −0.84742
  XPOT          0.857586           0.684634   KLF2         0.894365   −0.78132
  SCRIB         0.867393           0.771012   SMPD3        0.867973   −0.78767
  CCNA2         0.868501           0.7858     PPP1R3B      0.85511    −0.72434
  CCNB1         0.904717           0.755995   OGN          0.88218    −0.80725
  PRC1          0.886914           0.802267   ABI3BP       0.872052   −0.78816
  MRPL15        0.853847           0.663766   ITLN1        0.884383   −0.81818
  NUSAP1        0.867073           0.795277   MGARP        0.903375   −0.8306
  SLC52A2       0.868392           0.803613   ARHGAP18     0.918993   −0.80114
  TACC3         0.875177           0.752928   DDR2         0.852443   −0.67497
  KIF4A         0.871167           0.797892   ANTXR2       0.858928   −0.72284
  CEP55         0.850744           0.827425   LIX1L        0.878142   −0.68937
  DTL           0.865255           0.780689   MCC          0.870811   −0.71797
  KIF20A        0.888407           0.82511    TBRG1        0.85824    −0.79791
  CENPU         0.863996           0.732426   PTPN21       0.863405   −0.7201
  KIF15         0.882733           0.786989   CNRIP1       0.889837   −0.80871
  ECT2          0.916732           0.831958   PPM1K        0.895422   −0.86713
  CDCA8         0.85916            0.797452   MEDAG        0.866729   −0.84797
  MCM4          0.914084           0.813176   LINC01279    0.857322   −0.66728
  RACGAP1       0.918941           0.779139   PLEKHH2      0.865982   −0.76522
  PSAT1         0.854015           0.826163   SLC30A4      0.904509   −0.70542
  UBE2T         0.850996           0.725215   TCEAL3       0.856911   −0.7193
  SLC25A33      0.868987           0.6974     CDON         0.869831   −0.69303
  CDCA3         0.857304           0.797015   TCEAL7       0.870405   −0.84944
  NUF2          0.91985            0.868254   ERN1         0.880253   −0.77167
  RCC2          0.909521           0.783731   MUM1L1       0.899449   −0.85402
  FAM83D        0.901393           0.849648   RNASEL       0.872061   −0.72795
  POC1A         0.856044           0.816551   DOCK5        0.893588   −0.83622
  DEPDC1B       0.854264           0.764695   RBMS3        0.850965   −0.82463
  CENPL         0.857368           0.768059   HAND2-AS1    0.858159   −0.89488
  KIF14         0.902918           0.830047   DTWD1        0.879321   −0.75556
  FANCD2        0.890071           0.736399   IFFO1        0.857298   −0.73892

MM -- module membership; GS -- gene significance.

###### 

The Gene Set Enrichment Analysis (GSEA) of hub genes.

                              Description               setSize    enrichmentScore   NES        p.adjust                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              core_enrichment
  --------------------------- ------------------------- ---------- ----------------- ---------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  MAD2L1                      ALLOGRAFT REJECTION       120        0.438738          1.761702   0.007716                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              CDKN2A/NME1/GZMB/MMP9/CXCL9/CCL5/CXCL13/IL15/CCL11/EIF5A/TAP1/CCL13/GZMA/SRGN/IL2RG/CCL2/UBE2N/CCL7/HLA-DOB/CTSS/CCL4/B2M/CD3D/PRF1/CD2/LTB/TNF/SIT1/IL2RA/CD7/HLA-G/CD8A/CD3E/ST8SIA4/CD86/FCGR2B/IFNG/IL12A/CXCR3/LY86/CD8B/RIPK2/UBE2D1/TPD52/HLA-DQA1/MRPL3/CD80/WARS/CD79A/CCR1/LCK/HDAC9/IGSF6/BCL10/TRAT1/CAPG/CD3G/CD96/IL11/IL2RB/MAP4K1/KRT1
  E2F TARGETS                 105                       0.805846   3.155588          0.007716   MAD2L1/CDKN2A/BIRC5/CKS2/CKS1B/CCNE1/TK1/UBE2S/PTTG1/UBE2T/MYBL2/NME1/CCNB2/AURKB/PLK1/DEPDC1/KPNA2/CDC20/RRM2/CENPM/CDKN3/CDK1/PLK4/AURKA/PCNA/SNRPB/KIF2C/SPC25/TRIP13/JPT1/ASF1B/ORC6/H2AFX/TOP2A/MELK/RNASEH2A/TACC3/CDCA8/DLGAP5/KIF4A/DCTPP1/SPC24/RFC3/CENPE/HMMR/RAD51AP1/DIAPH3/STMN1/POP7/BUB1B/DCK/MTHFD2/RPA3/GINS1/SPAG5/RACGAP1/KIF22/GINS4/ DDX39A/DSCC1/CDC25A/KIF18B/RAN/E2F8/RFC2/TUBG1/SLBP/BRCA2/HMGB3/SUV39H1/CHEK1/PRIM2/GINS3/ESPL1/SMC4/MXD3                                                                                                                  
  G2M CHECKPOINT              104                       0.759634   2.975861          0.007716   MAD2L1/CCNA2/UBE2C/BIRC5/CKS2/CKS1B/UBE2S/PTTG1/MYBL2/PBK/CCNB2/AURKB/PLK1/KPNA2/CDC20/CENPA/CDKN3/TTK/CDK1/PLK4/NEK2/AURKA/GINS2/KIF2C/JPT1/ORC6/H2AFX/CDC45/TOP2A/TROAP/TACC3/CDC6/SNRPD1/TPX2/KIF4A/NUSAP1/CENPE/HMMR/NDC80/STMN1/BUB1/EXO1/DTYMK/KIF23/TRAIP/PRC1/RACGAP1/KIF22/E2F1/DDX39A/CDC25A/POLQ/KIF15/FBXO5/RAD54L/KNL1/KIF11/BRCA2/HMGB3/E2F2/SUV39H1/CHEK1/CENPF/PRIM2/ESPL1/SMC4/ODC1/CCNF/STIL/SMC2/CDC7/MCM6/HIST1H2BK/EZH2/MCM2                                                                                                                                     
  FANCD2                      G2M CHECKPOINT            104        0.901015          3.369604   0.006028                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              MYBL2/KIF15/TPX2/TOP2A/KIF2C/UBE2C/BIRC5/ESPL1/MAD2L1/HMMR/PBK/KIF4A/PLK1/TROAP/TTK/BUB1/CDC20/POLQ/ NUSAP1/RACGAP1/CCNB2/AURKB/CENPA/MKI67/CCNA2/KNL1/CDK1/TACC3/TRAIP/ PLK4/E2F2/CENPF/AURKA/KIF23/KIF11/ BRCA2/NEK2/CDC45/NDC80/EXO1/CDC25A/E2F1/CKS1B/CDC6/UBE2S/PRC1/KPNA2/RAD54L/CKS2/CENPE/SMC2/STIL/CCNF/LMNB1/CDKN3/PTTG1/STMN1/EZH2/ORC6/GINS2/CDC7/FBXO5/MCM2/ODC1/NSD2/H2AFX/KIF22/MCM6/INCENP/SMC4/CHEK1/DDX39A/KIF20B/BARD1/DTYMK/CHAF1A/SUV39H1
  E2F TARGETS                 105                       0.889041   3.34287           0.006028   MYBL2/CDKN2A/DEPDC1/MELK/CCNE1/ASF1B/TOP2A/KIF2C/TRIP13/BIRC5/ESPL1/BUB1B/MAD2L1/HMMR/KIF4A/PLK1/CDC20/CIT/CDCA8/SPAG5/SPC24/RACGAP1/CCNB2/AURKB/RRM2/TK1/MKI67/KIF18B/DLGAP5/CDK1/TACC3/PLK4/GINS4/AURKA/BRCA2/E2F8/RFC3/DIAPH3/SPC25/CDC25A/CKS1B/TIMELESS/UBE2S/RAD51AP1/KPNA2/CKS2/CENPE/GINS1/LMNB1/CDKN3/PTTG1/STMN1/UBE2T/CENPM/EZH2/ORC6/ATAD2/MCM2/MCM4/NCAPD2/HELLS/RNASEH2A/PCNA/H2AFX/KIF22/MCM6/SMC4/CHEK1/DDX39A/BARD1/DSCC1/GINS3/TCF19/SUV39H1/RFC2/CSE1L/UNG/MSH2/SNRPB/PRIM2/HMGB3/RAN/DCLRE1B/JPT1/NME1/TUBG1/DCK/MTHFD2/DCTPP1/TUBB/PAICS/DEK/PA2G4/DONSON/SLBP   
  MITOTIC SPINDLE             80                        0.798921   2.888574          0.006028   KIF15/TPX2/TOP2A/KIF2C/BIRC5/ESPL1/ KIF4A/PLK1/TTK/BUB1/ANLN/NUSAP1/RACGAP1/CCNB2/ECT2/DLGAP5/CDK1/CENPF/AURKA/KIF23/KIF11/BRCA2/NEK2/NDC80/PRC1/PIF1/CENPE/LMNB1/FBXO5/KIF22/INCENP/SMC4/KIF20B/CENPJ/SASS6                                                                                                                                                                                                                                                                                                                                                                          
  PKD2                        KRAS SIGNALING UP         118        0.656511          2.270659   0.004293                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              MMP11/PRRX1/PLAU/TMEM158/ETV1/CFH/GFPT2/LIF/PLAT/SPARCL1/ADGRA2/ TMEM176A/MMP9/LAPTM5/ITGB2/PCSK1N/TMEM176B/RGS16/EPB41L3/ENG/NRP1/TNFAIP3/IL2RG/APOD/MALL/EPHB2/IKZF1/PLAUR/WNT7A/MAFB/TFPI/AKAP12/TRIB2/KLF4/CXCL10/SPP1/BMP2/C3AR1/SPON1/ ETV5/ADAMDEC1/LCP1/FCER1G/FLT4/GYPC/G0S2/TRAF1/DUSP6/CTSS/ADAM8/SOX9/PPP1R15A/MMD/IRF8
  PKD2                        TNFA SIGNALING VIA NFKB   109        0.696773          2.395892   0.004293                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              SERPINE1/PLAU/FOSB/KLF2/ICAM1/GFPT2/LIF/EGR1/SLC2A3/FOS/ZFP36/DUSP1/EGR2/TNFAIP6/NR4A1/GEM/OLR1/CCL5/NR4A3/EGR3/TNFAIP3/LDLR/TNFAIP2/GADD45B/PLAUR/PLEK/NFAT5/CDKN1A/CCL2/KDM6B/KLF4/CXCL1/CXCL10/BMP2/SIK1/IL6ST/ DUSP4/FOSL2/CCL4/CXCL11/IER3/G0S2/ TRAF1/JUNB/F3/CD44/PPP1R15A/SERPINB2/RHOB/NR4A2/KLF9/SGK1/PTGER4/IFIT2/B4GALT5/MAFF/IER5/CXCL6/ETS2/PER1/BCL6/TAP1/TNFRSF9/SMAD3/ID2/PLPP3/IL1B/PTX3/SLC2A6/RNF19B/BIRC3/IFIH1
  INTERFERON GAMMA RESPONSE   107                       0.628308   2.160028          0.004293   C1S/CFH/CXCL9/ICAM1/C1R/XAF1/TNFAIP6/OAS2/IL2RB/LATS2/CCL5/CSF2RB/LCP2/ IFI44L/OAS3/HLA-DQA1/RSAD2/TNFAIP3/HLA-B/TNFAIP2/MX1/HELZ2/SLAMF7/ CDKN1A/CCL2/STAT1/CXCL10/FAS/EPSTI1/IFIT3/CD38/PIM1/TAPBP/CXCL11/SELP/CD74/WARS/ST8SIA4/IRF8/ST3GAL5/IFI44/LY6E/CD86/LGALS3BP/IFIT2/FCGR1A/OASL/EIF2AK2/MYD88/IFI30/CFB/TAP1/IFIT1/CMPK2/B2M/HLA-DRB1/PML/IFIH1/TXNIP/IFI27/HLA-G/ JAK2/TRIM14                                                                                                                                                                                             
  TBRG1                       ALLOGRAFT REJECTION       120        0.489708          1.924057   0.008729                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              IL18/THY1/LIF/CD74/HLA-DOA/HLA-DMA/HLA-DQA1/C2/HLA-DRA/LTB/IL2RG/FAS/ELF4/PRKCB/CD47/PRKCG/B2M/CD3E/LY75/ICAM1/INHBB/TAP1/TAPBP/IL2RB/HDAC9/CD2/IL16/CCL5/GZMA/FYB1/CD96/CD4/JAK2/CXCL9/IL15/STAB1/CD7/CCL4/ITGAL/HLA-DOB/IGSF6/IKBKB/HLA-G/ITGB2/LYN/TNF/IL12A/SPI1/PTPRC/CRTAM/CD8A/PRF1/CCL22/WAS/LCP2/CTSS/CD3D/FASLG/CXCR3
  TNFA SIGNALING VIA NFKB     109                       0.549517   2.128181          0.008729   BIRC3/IL18/CCND1/FOS/FOSB/LIF/CCL20/GADD45B/EGR1/CEBPD/EDN1/JUNB/SGK1/CCNL1/NR4A1/NFAT5/ZFP36/F3/IRF1/KLF2/TNFAIP2/IFIT2/CLCF1/SMAD3/ETS2/DUSP1/ICAM1/TAP1/LAMB3/MAFF/SERPINB2/PLAU/TRIB1/EGR3/BTG2/CCL5/TRAF1/IL6ST/CCL4/BTG3/TRIP10/TNFAIP3/IER3/TIPARP/EGR2/BMP2/TNF                                                                                                                                                                                                                                                                                                               
  INTERFERON GAMMA RESPONSE   107                       0.524759   2.03116           0.008729   CFB/XAF1/CD74/HLA-DMA/HLA-DQA1/IFITM3/HLA-DRB1/MX2/RTP4/PSMB8/IFI27/PSMB9/IRF1/IDO1/IFIT3/IFIT1/LY6E/FAS/TNFAIP2/ IFIT2/EPSTI1/B2M/ZBP1/TXNIP/ICAM1/TAP1/TAPBP/IL2RB/PML/TNFSF10/ITGB7/HLA-B/CCL5/CASP8/GZMA/SLC25A28/JAK2/C1R/CXCL9/IL15/NMI/SECTM1/MX1/HLA-G/TNFAIP3/UBE2L6/C1S/PARP12                                                                                                                                                                                                                                                                                              
  DOCK5                       TNFA SIGNALING VIA NFKB   109        0.558475          2.319462   0.007567                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              CD44/CCND1/FOSB/FOS/BIRC3/LAMB3/TNFAIP2/IL18/NFAT5/LDLR/EGR3/KLF2/EGR1/ZFP36/KLF9/BCL6/SIK1/SMAD3/DUSP1/ NR4A1/ETS2/IL6ST/SGK1/BTG2/CEBPD/GADD45B/DUSP4/PER1/KLF4/IRF1/EDN1/TRIP10/ICAM1/NR4A2/F3/TRAF1/SLC2A3/RHOB/FOSL2/IFIT2/STAT5A/CDKN1A/OLR1/KYNU/PLAU/LIF/TNFAIP3/CXCL1/MAFF/EGR2/JUNB/GFPT2/RIPK2/IL1B/RNF19B/F2RL1/ CXCL6/G0S2/PPP1R15A/PLEK/IER5/ICOSLG/TNFAIP8/TRIB1/MAP2K3
  INFLAMMATORY RESPONSE       104                       0.465585   1.916731          0.007567   SLC7A2/CD82/GPR132/STAB1/IL18/LDLR/TNFSF15/TAPBP/P2RX7/CYBB/PTAFR/BTG2/CLEC5A/TPBG/SLC7A1/MET/AHR/RASGRP1/IL2RB/IRF1/SGMS2/EDN1/LYN/ICAM1/ GABBR1/F3/TNFSF10/ITGB8/C3AR1/APLNR/LCP2/CDKN1A/OLR1/AQP9/LIF/RGS16/CCL22/RGS1/SELE/RTP4/RIPK2/IL1B/ITGA5/CXCL6/PCDH7/CD14/CCR7/SLC11A2/ICOSLG                                                                                                                                                                                                                                                                                             
  UV RESPONSE DN              62                        0.584505   2.210784          0.007567   CELF2/MGLL/RUNX1/IRS1/DLC1/RBPMS/LDLR/MT1E/SYNE1/SMAD3/PTPN21/DUSP1/GCNT1/PTPRM/VLDLR/SIPA1L1/CAV1/SLC7A1/MET/FHL2/PDGFRB/RND3/EFEMP1/F3/NRP1/ ANXA2/APBB2/PRDM2/PPARG                                                                                                                                                                                                                                                                                                                                                                                                                
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![Flow diagram of this study.](medscimonit-26-e922107-g001){#f1-medscimonit-26-e922107}

![The KEGG pathway enrichment analysis of differently-expressed genes. (**A**) KEGG pathways enrichment for upregulated genes. (**B**) KEGG pathways enrichment for downregulated genes.](medscimonit-26-e922107-g002){#f2-medscimonit-26-e922107}

![The GO enrichment analysis of differently-expressed genes. (**A**) GO enrichment analysis of upregulated genes. (**B**) GO enrichment analysis of downregulated genes.](medscimonit-26-e922107-g003){#f3-medscimonit-26-e922107}

![Co-expression modules construction and selection. (**A**) Samples clustering and trait heatmap of datasets from GEO according to the DEGs expression between HGSOC and normal tissue samples. (**B**) Dendrogram of all DEGs were clustered with dissimilarity according to topological overlap (1-TOM). (**C**) associations between modules and traits. In each cell, the upper number is the correlation coefficient of the module in the trait, and the lower number is the p value. Among them, the turquoise and blue modules were the most correlative with normal and cancer traits. (**D**) Distribution of average gene significance in the modules correlated with HGSOC. TOM -- topological overlap matrix.](medscimonit-26-e922107-g004){#f4-medscimonit-26-e922107}

![Select hub genes in significant co-expression modules. (**A**) The scatter plot of gene significance (GS) versus module membership (MM) in the blue module and turquoise module. (**B**) The heatmap presents the TOM among all genes. Colors beneath and right of the dendrograms explain the color-coding for each module. The more saturated yellow and red indicates a high co-expression inter-connectedness in the heatmap (**C**). Clustering of module eigengenes and the heatmap of the adjacencies.](medscimonit-26-e922107-g005){#f5-medscimonit-26-e922107}

![Protein--Protein Interaction (PPI) network of genes in 2 modules. (**A**) The genes in blue module. (**B**) The genes in turquoise module. The color presents the fold change (upregulated genes are red, downregulated genes are green).](medscimonit-26-e922107-g006){#f6-medscimonit-26-e922107}

![GO and KEGG pathway analysis of the 2 modules. (**A**) KEGG pathway analysis of blue module; (**B**) KEGG pathway analysis of turquoise module; (**C**) GO analysis of blue module; (**D**) GO analysis of turquoise module. GO analysis includes biological process (BP), cellular component (CC), and molecular function (MF). The count represents the number of genes in each pathway and dot size corresponds to "count".](medscimonit-26-e922107-g007){#f7-medscimonit-26-e922107}

![Kaplan-Meier analysis of (**A**) *MAD2L1*, (**B**) *PKD2*, (**C**) *DOCK5*, (**D**) *FANCD2*, and (**E**) *TBRG1* by comparing the higher (red) and lower (green) expressions with overall survival outcomes for patients with HGSOC.](medscimonit-26-e922107-g008){#f8-medscimonit-26-e922107}

![Validation of hub gene expressions in the TCGA and GTEx datasets. (**A**) *MAD2L1*, (**B**) *PKD2*, (**C**) *DOCK5*, (**D**) *FANCD2*, and (**E**) *TBRG1* gene expression differences between HGSOC and normal tissues.](medscimonit-26-e922107-g009){#f9-medscimonit-26-e922107}

![Gene set enrichment analysis (GSEA) of hub genes in the TCGA-OV dataset. Three gene sets enriched in the high-expressed group of single-hub genes. (**A**) *MAD2L1*, (**B**) *FANCD2*, (**C**) *PKD2*, (**D**) *TBRG1*, and (**E**) *DOCK5*.](medscimonit-26-e922107-g010){#f10-medscimonit-26-e922107}
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